[go: up one dir, main page]

MX9203173A - PHARMACEUTICAL COMPOSITION OF CONTROLLED RELEASE, BALANCED HYDRODYNAMICALLY. - Google Patents

PHARMACEUTICAL COMPOSITION OF CONTROLLED RELEASE, BALANCED HYDRODYNAMICALLY.

Info

Publication number
MX9203173A
MX9203173A MX9203173A MX9203173A MX9203173A MX 9203173 A MX9203173 A MX 9203173A MX 9203173 A MX9203173 A MX 9203173A MX 9203173 A MX9203173 A MX 9203173A MX 9203173 A MX9203173 A MX 9203173A
Authority
MX
Mexico
Prior art keywords
hydrodynamically
balanced
pharmaceutical composition
controlled release
release
Prior art date
Application number
MX9203173A
Other languages
Spanish (es)
Inventor
Prabhakar Ranchhordas Sheth
Jacques Levon Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9203173A publication Critical patent/MX9203173A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9203173A 1981-09-14 1992-06-23 PHARMACEUTICAL COMPOSITION OF CONTROLLED RELEASE, BALANCED HYDRODYNAMICALLY. MX9203173A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14

Publications (1)

Publication Number Publication Date
MX9203173A true MX9203173A (en) 1992-07-01

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203173A MX9203173A (en) 1981-09-14 1992-06-23 PHARMACEUTICAL COMPOSITION OF CONTROLLED RELEASE, BALANCED HYDRODYNAMICALLY.

Country Status (11)

Country Link
JP (1) JPS5857315A (en)
AT (1) AT385199B (en)
BE (1) BE894376A (en)
BG (1) BG60526B2 (en)
CH (1) CH652025A5 (en)
DE (1) DE3232873A1 (en)
FR (1) FR2512676B1 (en)
GB (1) GB2105590B (en)
IT (1) IT1158048B (en)
MX (1) MX9203173A (en)
NL (1) NL190746C (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (en) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd Medicinal drug and its preparation
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (en) * 1986-08-26 1989-12-11 Lejus Medical Ab A MULTIPLE-UNIT DOS COMPOSITION OF L-DOPA
DE3642668A1 (en) * 1986-12-13 1988-06-23 Kamprad Joachim Painkillers for people
DE3875716D1 (en) * 1987-12-31 1992-12-10 Asta Medica Ag SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLETS.
DE69017915T2 (en) * 1989-10-26 1995-07-27 Nippon Shinyaku Co Ltd PREPARATION FOR THE STOMACH.
DE4101873C2 (en) 1991-01-23 1993-12-09 Isis Pharma Gmbh Orally administrable drug form for the treatment of central dopamine deficiency states
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (en) * 1992-11-30 1992-11-30 Christer Nystroem DISPERSA SYSTEM MEDICINAL PRODUCT
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
JPH09504286A (en) * 1993-10-29 1997-04-28 レキット アンド コールマン プロダクツ リミテッド Effervescent gelatin capsule filling
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
AU2003282603A1 (en) * 2002-10-11 2004-05-04 Depomed Development Ltd Gastro-retentive levodopa delivery form
DE102004039196B4 (en) 2004-08-12 2008-07-31 Dr.Kamprad Kg New formulation for L-tryptophan
DE102010023828A1 (en) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmaceutical preparation containing entacapone, levodopa and carbidopa
DE102014003744A1 (en) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Product for oral administration to humans or animals with microstructured encapsulated ingredients, and apparatus for making such a product, and method of making the same
DE102022103658A1 (en) 2022-02-16 2023-08-17 Joachim Kamprad Drug composition containing L-tryptophan (L-Try) and L-5-hydroxytryptophan (5-HTP) and a peripheral degradation inhibitor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (en) * 1961-06-16 1966-03-31 Hoffmann La Roche Process for the preparation of substituted hydrazines
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (en) * 1972-02-14 1973-08-23 Hoffmann La Roche PHARMACEUTICAL PREPARATION
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Also Published As

Publication number Publication date
CH652025A5 (en) 1985-10-31
ATA341582A (en) 1987-08-15
GB2105590A (en) 1983-03-30
IT1158048B (en) 1987-02-18
AT385199B (en) 1988-02-25
FR2512676A1 (en) 1983-03-18
JPS5857315A (en) 1983-04-05
NL8203343A (en) 1983-04-05
BE894376A (en) 1983-03-14
NL190746C (en) 1994-08-01
BG60526B2 (en) 1995-07-28
DE3232873A1 (en) 1983-03-31
FR2512676B1 (en) 1987-01-23
IT8223147A0 (en) 1982-09-07
JPH0341447B2 (en) 1991-06-24
NL190746B (en) 1994-03-01
GB2105590B (en) 1985-05-30

Similar Documents

Publication Publication Date Title
MX9203173A (en) PHARMACEUTICAL COMPOSITION OF CONTROLLED RELEASE, BALANCED HYDRODYNAMICALLY.
NO821087L (en) PROCEDURE FOR THE PREPARATION OF CYCLOBUTAN DERIVATIVES.
DK528982A (en) PROCEDURE FOR THE PREPARATION OF 13,14-DIDEHYDRO-PROSTAGLANDINES
ES524185A0 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF PIRIMIDINE OR S-TRIACINE.
ES514795A0 (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED DERIVATIVES OF PIRIDAZINE.
ES517862A0 (en) DERIVATIVES OF ALCANOSULFONANILIDA.
ES514887A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF PIRIDAZINE.
ES522446A0 (en) PROCEDURE FOR THE PREPARATION OF ALPHA-HALOBENCIL-ALPHA- (3-PIRIDIL OR 2-PIRIZINYL) -ALCANOLS.
ES516864A0 (en) PROCEDURE FOR THE PREPARATION OF PENEM DERIVATIVES.
ES513792A0 (en) PROCEDURE FOR THE PREPARATION OF AMIDOBENZAMIDES.
ES511220A0 (en) "PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES 4-AMINOETOXI-5-ISOPROPIL-2-METHYL".
NO155693C (en) PROCEDURE FOR THE PREPARATION OF EBURNAMONIN DERIVATIVES.
AR227335A1 (en) PROCEDURE FOR THE PREPARATION OF ALPHA- (3,4,5-TRIMETOXIBENZOILTIO) -PROPIONILGLICINA
ES510730A0 (en) "PROCEDURE FOR THE PREPARATION OF (2,2 ') - DITIAZOLYL DISULFURES".
ES509761A0 (en) "PROCEDURE FOR THE PREPARATION OF 1,2 BENZISOXAZOLOXIETILAMINES".
ES513974A0 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 3,4-DIPHENYL-5-METHYL PIRAZOLE.
ES518033A0 (en) PROCEDURE FOR THE PREPARATION OF (-) - 2-1- (2,6-DICLOROFENOXI) -ETIL-1,3-DIAZACICLOPENT-2-ENO.
ES519351A0 (en) PROCEDURE FOR THE PREPARATION OF BENZOTRIAZOLES.
IT8122813A0 (en) PROCEDURE FOR THE PREPARATION OF N-CYCLOHEXYLBENZOTHIAZOL-2-SULPHENAMI DE.
ES510963A0 (en) PROCEDURE FOR THE PREPARATION OF ALCOXIAMINOHIDRIDOSILANOS.
ES517428A0 (en) PROCEDURE FOR THE PREPARATION OF BENCILIDENIC DERIVATIVES.
ES511914A0 (en) 1,5-SUBSTITUTED ISOQUINOLINE DERIVATIVES.
ES514224A0 (en) "PROCEDURE FOR THE PREPARATION OF 2,4-DIAMINO- (3,5-DIMETOXI-4-METOXIETOXIBENZIL) -PIRIMIDINA".
ES517888A0 (en) PROCEDURE FOR THE PREPARATION OF THIOALCANOYL-CARNITINES.
MX159206A (en) PROCEDURE FOR PREPARING DERIVATIVES OF 20.21 DINOREBURNAMENINE